Vanda Pharmaceuticals
VNDA
VNDA
148 hedge funds and large institutions have $246M invested in Vanda Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8.89% less ownership
Funds ownership: 83.69% → 74.8% (-8.9%)
40% less call options, than puts
Call options by funds: $1.23M | Put options by funds: $2.04M
Holders
148
Holding in Top 10
–
Calls
$1.23M
Puts
$2.04M
Top Buyers
| 1 | +$6.53M | |
| 2 | +$3.74M | |
| 3 | +$3.28M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.27M |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$2.25M |
Top Sellers
| 1 | -$6.39M | |
| 2 | -$6.27M | |
| 3 | -$5.71M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.26M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3M |